Loading...
OTCM
SPOM
Market cap152kUSD
Jun 12, Last price  
0.00USD
1D
-5.71%
1Q
32.00%
Jan 2017
120.00%
Name

SPO Global Inc

Chart & Performance

D1W1MN
P/E
0.08
P/S
0.01
EPS
0.01
Div Yield, %
—
Shrs. gr., 5y
109.75%
Rev. gr., 5y
215.39%
Revenues
12m
+298.62%
01,825,0003,714,0005,008,0002,759,0001,047,000192,00020,000316,000556,000461,000301,136114,999450,54639,85082,35615,797,06831,766,1413,119,81912,436,288
Net income
2m
+3,458.66%
-7,760-2,038,000-4,963,000-1,604,000-3,201,000-477,000-2,174,000-1,607,000-888,000-683,000-594,000-309,932-15,085,345-230,697-172,364-1,203,971276,1162,377,60854,4121,936,337
CFO
9m
P
-11,253-1,209,000-443,000-559,000-1,158,000132,000-993,000-362,000-336,000-274,000-694,0005,782-256,20623,625-601,0730-5,381,6570-55,7499,142,995

Profile

Gerpang Healthcare Group operates as a bio-pharmaceutical company that manufactures and sells genetic coating stents, HBV hepatitis B virus vaccines, monoclonal antibodies for male infertility detection, ognitive disorder functional food, and polypeptide probiotics. The company was founded in 2006 and is based in Jinan, China.
URL
https://www.gerpanghealthcare.com
IPO date
Aug 11, 1995
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
12,436
298.62%
3,120
-90.18%
Cost of revenue
9,243
2,696
Unusual Expense (Income)
NOPBT
3,193
424
NOPBT Margin
25.68%
13.59%
Operating Taxes
84
2
Tax Rate
2.61%
0.00%
NOPAT
3,110
424
Net income
1,936
3,458.66%
54
-97.71%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
272
241
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
(3,087)
(854)
Cash flow
Cash from operating activities
9,143
(56)
CAPEX
(2,245)
Cash from investing activities
(6,937)
Cash from financing activities
57
128
FCF
8,804
897
Balance
Cash
3,359
1,095
Long term investments
Excess cash
2,737
939
Stockholders' equity
(18,851)
(20,868)
Invested Capital
25,358
30,883
ROIC
11.06%
1.36%
ROCE
49.07%
4.23%
EV
Common stock shares outstanding
342,973
252,973
Price
Market cap
EV
EBITDA
3,732
448
EV/EBITDA
Interest
2
19
Interest/NOPBT
0.05%
4.54%